Concepedia

Author

Peter Blumencranz

The University of Texas MD Anderson Cancer Center

Also Known As

Brennan, Meghan B., P Blumencranz, P Whitworth, P. Blumencranz, P. W. Blumencranz, Peter Blumencranz, Peter W Blumencranz, Peter W. Blumencranz, Peter William Blumencranz

67

Publications

6.1K

Citations

20

H-Index

36

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterMorton Plant HospitalThe University of Texas Southwestern Medical CenterDallas Surgical GroupMemorial Sloan Kettering Cancer Center
PB

About

Peter Blumencranz is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, breast cancer, and surgical oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

530

2

Health Sciences

6

6

320

3

Engineering

1

1

24

4

Biomedical Engineering

1

1

24

5

Cell Biology

1

1

56

Peter Blumencranz

×

22

Publications

5.6K

Citations

18

H-Index

YearCitations

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

Armando E. Giuliano, Karla V. Ballman, Linda McCall,

JAMA

2017

1.8K

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

Armando E. Giuliano, Linda McCall, Peter D. Beitsch,

Annals of Surgery

2010

1.2K

Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011

Anthony Lucci, Linda McCall, Peter D. Beitsch,

Journal of Clinical Oncology

2007

893

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

Armando E. Giuliano, Karla V. Ballman, Linda McCall,

Annals of Surgery

2016

490

Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer

Armando E. Giuliano, Debra Hawes, Karla V. Ballman,

JAMA

2011

262

Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011

John A. Olson, Linda McCall, Peter D. Beitsch,

Journal of Clinical Oncology

2008

120

Sentinel Node Skills Verification and Surgeon Performance

Katherine E. Posther, Linda McCall, Peter Blumencranz,

Annals of Surgery

2005

106

Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors

Peter Blumencranz, Pat W. Whitworth, Kenneth Deck,

The American Journal of Surgery

2007

105

A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision

Charles E. Cox, Vanessa Prowler, Ebonie Carter,

Annals of Surgical Oncology

2016

98

ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node.

A. E. Giuliano, Linda McCall, Peter D. Beitsch,

Journal of Clinical Oncology

2010

91

Page 1